Credo Technology Just Made a Promise It Has to Keep

The company’s spectacular growth is old news; the real story is a massive bet on a new business that has to work, and soon.

At first glance, Credo Technology (CRDO)’s quarter looked like another victory lap. Revenue of $437.0 million was up a blistering 157.0% from a year ago. For the full fiscal year, sales more than tripled to $1.3 billion. So why did the stock barely budge, rising just 1.3% the next day?

Because the market has already moved on. This earnings report wasn’t about the incredible year Credo just finished. It was about the colossal, and considerably riskier, promise management just made for the year ahead. The company has effectively bet its entire growth story on a massive pivot to a new product line, and the clock is ticking.

The New Six-Hundred-Million-Dollar Mandate

Forget the rearview mirror. The number that matters now is management’s forecast for “more than 80% year-over-year total revenue growth for the full year” in fiscal 2027. That’s an audacious target off a record-setting base. But here’s the catch: that growth isn’t coming from more of the same.

Management was explicit that they expect an “inflection beginning in the second half,” driven by their emerging optics business. How big an inflection? They put a number on it: “more than $600 million in optical revenue.” This new engine is expected to fire on all cylinders, with three distinct product lines, optical DSPs, silicon photonics, and ZeroFlap optics, each set to “contribute more than $100 million of revenue.” This isn’t a side project. It’s the new center of gravity for the company.

A Back-Loaded Bet

If you’re an investor, this guidance should focus your attention. The company is signaling a relatively quiet start to the year, with “mid-single-digit sequential growth in the first half.” All the fireworks, and therefore all the execution risk, are packed into the last six months.

This makes Credo a classic “show-me” story. The company has to build, ship, and get paid for a whole new business at massive scale and do it in a hurry. Complicating matters is what the CEO acknowledged on the call as “a significant tightness in the supply chain.” That’s the primary external threat that could derail this perfectly timed plan. While management expressed confidence, it’s a variable they don’t fully control.

What to Watch Now

For the next two quarters, you can largely ignore the headline revenue and EPS figures. The story for Credo now boils down to a single question: is the optical ramp on track? The company has staked its 80%-plus growth target on it.

The most important data point from here won’t be in a press release table. It will be any and all commentary from management that confirms, updates, or walks back that $600 million optical revenue target. That number is everything. Watch it like a hawk.

So, What Should You Do?

Reacting to a single earnings print is its own kind of risk. The Trefis High Quality (HQ) Portfolio takes the other side of that bet: 30 quality names, sized and rebalanced with discipline, and a track record of outpacing the S&P 500, S&P Mid-cap, and Russell 2000. When it comes to protecting and growing wealth over the long term, a disciplined portfolio approach pays much better than concentrated single stock bets.